We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$266M
AUM Growth
-$43.4M
Cap. Flow
-$44.2M
Cap. Flow %
-16.65%
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22

Top Sells

Rank Stock Value
1
RH icon
RH
RH
+$13M
2
MGNX icon
MacroGenics
MGNX
+$6.84M
3
BABA icon
Alibaba
BABA
+$3.42M
4
SGMO
SANGAMO THERAPEUTICS INC
SGMO
+$3.21M
5
HCA icon
HCA Healthcare
HCA
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 23.9%
2 Communication Services 19.6%
3 Energy 16.27%
4 Industrials 12.61%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
101
Boeing
BA
$166B
-8,185
Closed -$1.04M
BABA icon
102
Alibaba
BABA
$296B
-38,500
Closed -$3.42M
FCX icon
103
Freeport-McMoran
FCX
$110B
-7,600
Closed -$248K
LVS icon
104
Las Vegas Sands
LVS
$29.2B
-7,300
Closed -$454K
META icon
105
Meta Platforms (Facebook)
META
$1.47T
-21,086
Closed -$1.67M
OPK icon
106
Opko Health
OPK
$1.1B
-137,000
Closed -$1.17M
RH icon
107
RH
RH
$2.83B
-163,733
Closed -$13M
SGMO
108
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-298,000
Closed -$3.21M
VOD icon
109
Vodafone
VOD
$37.1B
-59,706
Closed -$1.96M
WYNN icon
110
Wynn Resorts
WYNN
$9.81B
-2,500
Closed -$468K
ICPT
111
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-4,300
Closed -$1.02M
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
-20,500
Closed -$930K
STML
113
DELISTED
Stemline Therapeutics, Inc.
STML
-31,064
Closed -$387K
VIAB
114
DELISTED
Viacom Inc. Class B
VIAB
-5,500
Closed -$423K
MBLY
115
DELISTED
Mobileye N.V.
MBLY
-22,300
Closed -$1.2M
NPSP
116
DELISTED
NPS PHARMACEUTICALS INC
NPSP
-16,000
Closed -$416K
TI
117
DELISTED
Telecom Italia
TI
-11,500
Closed -$132K

Similar funds

Private Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.

  • Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
  • Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
  • Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
  • Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
  • Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
  • Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
  • Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.

Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.